Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease.
Ayyala D, Bottyan T, Tien C, Pimienta M, Yoo J, Stager K, Gonzalez JL, Stolz A, Dodge JL, Terrault NA, Han H.
Ayyala D, et al. Among authors: pimienta m.
Hepatol Commun. 2022 Dec;6(12):3433-3442. doi: 10.1002/hep4.2080. Epub 2022 Oct 25.
Hepatol Commun. 2022.
PMID: 36281979
Free PMC article.